Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 16, 2017

View Archived Issues

FDA grants priority review to Verzenio NDA

ZIKV-neutralizing monoclonal antibody cocktail shows promise in nonhuman primates

ASN-100 shows good safety and PK profile for treating Staphylococcus aureus pneumonia

Unacyclated ghrelin analogue from Alize Pharma granted FDA orphan status for Prader-Willi syndrome

FDA accepts ProMetic's BLA for Ryplazim

New PET tracer is specific for bacterial infections

NIH and 11 biopharmaceutical companies partner to launch PACT cancer immunotherapy collaboration

FDA advisory committee votes in favor of Rhopressa

Merz and Teijin sign license and codevelopment agreement for Xeomin in Japan

Impact Biomedicines launched to develop fedratinib for myelofibrosis

Novel NRXN1 gene mutations associated with increased risk of ASD and schizophrenia

SKYZoster approved in South Korea

Janssen, Katholieke Universiteit Leuven describe novel dengue viral replication inhibitors

FDA approves Stelara for adolescents with moderate to severe plaque psoriasis

Toray Industries divulges new dolastatin 10 derivatives

Lysine-specific demethylase 5A inhibitors patented by KIST, Hanyang University

Sun Pharma Advanced Research Co. presents Bruton tyrosine kinase inhibitors

Free fatty acid receptor 1 agonists patented by Merck & Co.

Japan Tobacco enters licensing agreement for Rayaldee in Japan

Genentech, Xenon Pharmaceuticals discover new SCN9A channel blockers

Wellcome announces launch of Global Burden of Disease AMR project

EMA's CHMP supports expansion of marketing authorization for Zytiga

BrainStorm initiates phase III trial of NurOwn for ALS

Health Canada first to approve Shingrix

CLDN5 gene linked to autism pathology

Karyopharm Therapeutics and Ono enter SINE compound agreement

Inotek Pharmaceuticals files statement regarding proposed merger with Rocket Pharmaceuticals

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...